Coeptis Therapeutics Inc.
COEP | NASDAQ
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -9.77M | -4.02M | -1.62M | -2.74M | -4.33M | -3.42M | -3.01M | -1.83M | -3.04M | -3M | -3.76M | -6.26M | -3.11M | -7.87M | -2.94M | -5.65M | -9.8M | -19.18M | -1.22M | -5.95M | -1.8M | -1.95M |
Depreciation & Amortization | 847K | 310.51K | 306.01K | 305.77K | 305.53K | 305.3K | 259.98K | 278.23K | 250.21K | 259.34K | 250.31K | 250.31K | 250.31K | 250.31K | 250.35K | 250.35K | 250.35K | 250.35K | 446.2K | 366 | 367 | 481 |
Stock-Based Compensation | 5.62M | 1.42M | 213.91K | n/a | 191.02K | 597.73K | 299.63K | 96.89K | 611.57K | 96.89K | n/a | 113.3K | 113.3K | 122.39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | n/a | 368.33K | -70.01K | -282.65K | -647.39K | -71.65K | -97.18K | 8.08K | 55.73K | 201.15K | 7.8K | 94.65K | 56.26K | 43.55K | -669.08K | 54.32K | 40.91K | 66.66K | -3.05M | -1.06M | 33.44K | 336.25K |
Other Non-Cash Items | 4.87M | 52.52K | -694.72K | 861.3K | 2.21M | 372.5K | 1.06M | -300K | 784.85K | 665.03K | 904.14K | 4.85M | 351K | 5.62M | 2.74M | 4.26M | 8.45M | 17.79M | 104.09K | 4.81M | 1.65M | 770K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.09M | 286.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 482.81K | 109.8K | -579.88K | -769.22K | -220.76K | -44.29K | -138.83K | -29.02K | 77.74K | 907.35K | 181.43K | 209.04K | 195.05K | -897.93K | 105.65K | 64.58K | 177.37K | -3.05M | -2.51M | 33.44K | 524.33K |
Operating Cash Flow | 1.56M | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M | -1.68M | -847.35K | -1.03M | -1.03M | -961.73K | -4.17M | -3.65M | -122.21K | -655.27K |
Capital Expenditures | n/a | -3 | n/a | -3 | n/a | n/a | n/a | n/a | 1 | n/a | -2 | n/a | n/a | n/a | n/a | -1 | 1 | n/a | n/a | -4.05M | 5 | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 333.34K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -506.11K | 506.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -43.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -85.41K | 85.41K | n/a | n/a | n/a | n/a | 100K | n/a | n/a | -100K | n/a | 350K | -350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -591.52K | 591.52K | n/a | n/a | n/a | n/a | 100K | n/a | n/a | -100K | n/a | 350K | -350K | n/a | -42.69M | n/a | n/a | n/a | -1.75M | -4.05M | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 771.25K | -63.47K | n/a | 200K | 1.06M | -200K | -725K | 350K | n/a | -2.59M | -50K | n/a | -250K | -1.62M | 4.75M | -931.91K | -122.41K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -247.17K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 14.99M | 504.25K | n/a | 5.06M | 125K | 400 | n/a | -50K | 50K | n/a | 200K | n/a | n/a | n/a | -141.44K | 8.52M | 382.5K | 110K | -50.9K | 1.29M | n/a | -298.06K |
Financial Cash Flow | 14.99M | 704.25K | 2.45M | 5.06M | 125.1K | 6.1M | 731.97K | 1.47M | 1.94M | 1.56M | 1.75M | -224.93K | 3.39M | n/a | -2.73M | 6.03M | 1.07M | 1.13M | 8.22M | 8.6M | 601.72K | 2.49M |
Net Cash Flow | 10.28M | -463.11K | 765.82K | 2.91M | -2.27M | 3.74M | -604.57K | -417.62K | 525.83K | -439.89K | 57.62K | -1.83M | 1.14M | -1.68M | -3.58M | -70.32K | -82.22K | 164.27K | 1.59M | 898.56K | -122.21K | 1.83M |
Free Cash Flow | 1.56M | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M | -1.68M | -847.35K | -1.03M | -1.03M | -961.73K | -4.17M | -7.7M | -122.2K | -655.27K |
Adj. Free Cash Flow | -4.06M | -3.18M | -1.9M | -2.15M | -2.59M | -2.96M | -1.74M | -1.99M | -2.03M | -2M | -1.69M | -2.07M | -2.02M | -1.81M | -847.35K | -1.03M | -1.03M | -961.73K | -4.17M | -7.7M | -122.2K | -655.27K |
Maintenance CapEx | n/a | -3 | n/a | n/a | n/a | n/a | n/a | n/a | 1 | n/a | -2 | n/a | n/a | n/a | n/a | -1 | 1 | n/a | n/a | -4.05M | 5 | n/a |
Growth CapEx | n/a | n/a | n/a | -3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | 1.56M | -1.76M | -1.69M | -2.15M | -2.4M | -2.37M | -1.44M | -1.89M | -1.42M | -1.9M | -1.69M | -1.96M | -1.9M | -1.68M | -847.35K | -1.03M | -1.03M | -961.73K | -4.17M | -7.7M | -122.2K | -655.27K |
Add to Watchlist
Select watchlists to add or remove COEP